ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells. 2015

Rimpei Morita, and Mayu Suzuki, and Hidenori Kasahara, and Nana Shimizu, and Takashi Shichita, and Takashi Sekiya, and Akihiro Kimura, and Ken-ichiro Sasaki, and Hideo Yasukawa, and Akihiko Yoshimura
Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo 160-8582, Japan; Core Research for Evolutional Science and Technology Program, Japan Science and Technology Agency, Tokyo 102-0076, Japan; rimpeim@a7.keio.jp yoshimura@a6.keio.jp.

Transplantation of endothelial cells (ECs) is a promising therapeutic approach for ischemic disorders. In addition, the generation of ECs has become increasingly important for providing vascular plexus to regenerated organs, such as the liver. Although many attempts have been made to generate ECs from pluripotent stem cells and nonvascular cells, the minimum number of transcription factors that specialize in directly inducing vascular ECs remains undefined. Here, by screening 18 transcription factors that are important for both endothelial and hematopoietic development, we demonstrate that ets variant 2 (ETV2) alone directly converts primary human adult skin fibroblasts into functional vascular endothelial cells (ETVECs). In coordination with endogenous FOXC2 in fibroblasts, transduced ETV2 elicits expression of multiple key endothelial development factors, including FLI1, ERG, and TAL1, and induces expression of endothelial functional molecules, including EGFL7 and von Willebrand factor. Consequently, ETVECs exhibits EC characteristics in vitro and forms mature functional vasculature in Matrigel plugs transplanted in NOD SCID mice. Furthermore, ETVECs significantly improve blood flow recovery in a hind limb ischemic model using BALB/c-nu mice. Our study indicates that the creation of ETVECs provides further understanding of human EC development induced by ETV2.

UI MeSH Term Description Entries
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D001808 Blood Vessels Any of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins). Blood Vessel,Vessel, Blood,Vessels, Blood
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D016513 Mice, SCID Mice homozygous for the mutant autosomal recessive gene "scid" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice. SCID Mice,SCID-hu Mice,Severe Combined Immunodeficient Mice,Immunodeficient Mice, Severe Combined,Mouse, SCID,Mouse, SCID-hu,Mice, SCID-hu,Mouse, SCID hu,SCID Mouse,SCID hu Mice,SCID-hu Mouse
D016688 Mice, Inbred NOD A strain of non-obese diabetic mice developed in Japan that has been widely studied as a model for T-cell-dependent autoimmune insulin-dependent diabetes mellitus in which insulitis is a major histopathologic feature, and in which genetic susceptibility is strongly MHC-linked. Non-Obese Diabetic Mice,Mice, NOD,Mouse, Inbred NOD,Mouse, NOD,Non-Obese Diabetic Mouse,Nonobese Diabetic Mice,Nonobese Diabetic Mouse,Diabetic Mice, Non-Obese,Diabetic Mice, Nonobese,Diabetic Mouse, Non-Obese,Diabetic Mouse, Nonobese,Inbred NOD Mice,Inbred NOD Mouse,Mice, Non-Obese Diabetic,Mice, Nonobese Diabetic,Mouse, Non-Obese Diabetic,Mouse, Nonobese Diabetic,NOD Mice,NOD Mice, Inbred,NOD Mouse,NOD Mouse, Inbred,Non Obese Diabetic Mice,Non Obese Diabetic Mouse
D042783 Endothelial Cells Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer. Capillary Endothelial Cells,Lymphatic Endothelial Cells,Vascular Endothelial Cells,Capillary Endothelial Cell,Cell, Capillary Endothelial,Cell, Endothelial,Cell, Lymphatic Endothelial,Cell, Vascular Endothelial,Cells, Capillary Endothelial,Cells, Endothelial,Cells, Lymphatic Endothelial,Cells, Vascular Endothelial,Endothelial Cell,Endothelial Cell, Capillary,Endothelial Cell, Lymphatic,Endothelial Cell, Vascular,Endothelial Cells, Capillary,Endothelial Cells, Lymphatic,Endothelial Cells, Vascular,Lymphatic Endothelial Cell,Vascular Endothelial Cell

Related Publications

Rimpei Morita, and Mayu Suzuki, and Hidenori Kasahara, and Nana Shimizu, and Takashi Shichita, and Takashi Sekiya, and Akihiro Kimura, and Ken-ichiro Sasaki, and Hideo Yasukawa, and Akihiko Yoshimura
May 2012, Current opinion in hematology,
Rimpei Morita, and Mayu Suzuki, and Hidenori Kasahara, and Nana Shimizu, and Takashi Shichita, and Takashi Sekiya, and Akihiro Kimura, and Ken-ichiro Sasaki, and Hideo Yasukawa, and Akihiko Yoshimura
February 2020, Biochemical and biophysical research communications,
Rimpei Morita, and Mayu Suzuki, and Hidenori Kasahara, and Nana Shimizu, and Takashi Shichita, and Takashi Sekiya, and Akihiro Kimura, and Ken-ichiro Sasaki, and Hideo Yasukawa, and Akihiko Yoshimura
March 2017, Circulation research,
Rimpei Morita, and Mayu Suzuki, and Hidenori Kasahara, and Nana Shimizu, and Takashi Shichita, and Takashi Sekiya, and Akihiro Kimura, and Ken-ichiro Sasaki, and Hideo Yasukawa, and Akihiko Yoshimura
August 2018, Developmental biology,
Rimpei Morita, and Mayu Suzuki, and Hidenori Kasahara, and Nana Shimizu, and Takashi Shichita, and Takashi Sekiya, and Akihiro Kimura, and Ken-ichiro Sasaki, and Hideo Yasukawa, and Akihiko Yoshimura
July 2018, Current opinion in hematology,
Rimpei Morita, and Mayu Suzuki, and Hidenori Kasahara, and Nana Shimizu, and Takashi Shichita, and Takashi Sekiya, and Akihiro Kimura, and Ken-ichiro Sasaki, and Hideo Yasukawa, and Akihiko Yoshimura
May 2015, EMBO reports,
Rimpei Morita, and Mayu Suzuki, and Hidenori Kasahara, and Nana Shimizu, and Takashi Shichita, and Takashi Sekiya, and Akihiro Kimura, and Ken-ichiro Sasaki, and Hideo Yasukawa, and Akihiko Yoshimura
December 2020, Arteriosclerosis, thrombosis, and vascular biology,
Rimpei Morita, and Mayu Suzuki, and Hidenori Kasahara, and Nana Shimizu, and Takashi Shichita, and Takashi Sekiya, and Akihiro Kimura, and Ken-ichiro Sasaki, and Hideo Yasukawa, and Akihiko Yoshimura
January 2016, Current topics in developmental biology,
Rimpei Morita, and Mayu Suzuki, and Hidenori Kasahara, and Nana Shimizu, and Takashi Shichita, and Takashi Sekiya, and Akihiro Kimura, and Ken-ichiro Sasaki, and Hideo Yasukawa, and Akihiko Yoshimura
December 2015, Molecules and cells,
Rimpei Morita, and Mayu Suzuki, and Hidenori Kasahara, and Nana Shimizu, and Takashi Shichita, and Takashi Sekiya, and Akihiro Kimura, and Ken-ichiro Sasaki, and Hideo Yasukawa, and Akihiko Yoshimura
January 2013, PLoS biology,
Copied contents to your clipboard!